Head of In Vivo Operations
Company: Capable
Location: San Francisco, CA
Salary: $100,000 - $150,000 a year
Type: Full-time
Posted: 2026-03-16
About this role
# Head of In Vivo Operations & Vivarium Technician
San Francisco, CA – Full-Time – On-site – $100,000 - $150,000 per year.
*$10k referral bonus* *for successful hires (half equity, half cash).*
It's Monday morning. You walk in, grab your coffee, and look at the vivarium you helped build from scratch. Your vivarium. You check the board. First up: feed the mice. These are your mice - you set them up, you're responsible for everything that happens in this room.
A vendor calls. Shipment delayed on the IVC rack you urgently need. Two weeks ago, you would've accepted that. Not anymore. You've learned to find the bottleneck and solve it. Thirty minutes later, the shipment is back on track.
Then the chemist hands you a peptide - just synthesized in the rapid in-house pipeline and ready to be tested. Today it's IV injections. You didn't know how to do that before you got here. Now it's one of a dozen skills you picked up in weeks, not months.
This peptide didn't exist 24 hours ago. Our in-house ML model designed it last night. Is it going to outperform the last version? You dose the mice, set everything up in the in-house ML tracking system, and two hours later – results.
The Mission
In the age of ever-improving AI capabilities, we humans are lagging behind. We're hungry, distractable, tired. A third of our day is spent unconscious. Half of us get cancer, half of us get heart disease. We're incapable of sustained high performance. We fall ill. The modern world feeds us slop that leads even further down the drain.
We believe that humans are capable of more.
*We believe in excellence. We believe in superpowers. We believe in the extraordinary.*
We're a small core team. In 6 months, we have designed 270+ therapeutic candidates, run 72+ placebo-controlled mouse trials, and completed 79 custom syntheses. We're planning first-in-human safety in 2026 — which would be a world record for a non-vaccine therapeutic built from scratch. Our founding scienti...